In even the most troubling times for medtech, start-up investors and executives point to the one undeniable truth of the industry – Big Medtech manufactures need start-ups as a source of innovation. Business and development executives from large medtech companies acknowledge and even embrace this maxim, but troubling facts remain.
Medtech Buyers Mull Mega-Mergers, Earn-Outs, And Google
Even with a surge in IPO opportunities, M&A remains the primary – almost exclusive – exit route for medtech investors and entrepreneurs. A panel of business development professionals speaking at the recent IN3 360° Boston conference presented insights on how start-ups might improve their chances of being acquired.